Human Mixtard 30/70 Injection 40 IU 10ml Vial

Human Mixtard 30/70 Injection 40 IU 10ml Vial

Prescription requiredRx Required
Refrigerated 2–8°C · Online payment only

Salt Composition: Insulin Isophane (70%) + Human insulin (30%)

Expiry Date: 01/2028

Special offer

Buy at $3.78

$3.78

Inclusive of all taxes

10ml

About The Product

Twice-daily insulin for both meal and daily sugar control.


Description

Human Mixtard 30/70 Injection 40 IU 10ml is used to improve low blood sugar in type 1 and type 2 diabetes in both adults and children. The medicine contains two drugs, Insulin Isophane (70%) + Human insulin (30%), which belongs to the group of antidiabetic agents (Insulin) used for hormone replacement therapy to regulate blood glucose level. It contains insulin that promotes glucose uptake into muscle and fat cells, inhibiting glucose production by the liver. A doctor's prescription is highly required in the treatment to enhance the effectiveness of the medicine.

Uses

  • Improve blood sugar level

Side Effects

Every medication contains some acute and mild side effects, such as Human Mixtard 30/70 Injection cause certain symptoms that are manageable in some patients but some need proper medical attention to treat. Common ones include:

  • Low blood sugar (Hypoglycaemia)
  • Lightheadedness
  • Dizziness
  • Anxiety
  • Nervousness
  • Tiredness
  • Feeling hungry
  • Visual disturbances
  • Headache
  • Shaking
  • Sweating
  • Pale skin
  • Skin rashes
  • Pain, redness, swelling at the injection site.

How To Use

  • Human Mixtard 30/70 Injection 40 IU 10ml should be taken on the thigh, upper arms, abdomen, and buttocks by a doctor or nurse.
  • The medication can be used before or after a meal to help control blood sugar levels effectively, and the injection site should be rotated regularly to prevent skin problems such as lipodystrophy or irritation.
  • Do not self-administer the medication; the correct dosage and duration are administered by the healthcare professional only.
  • Follow the recommended dosage as prescribed to improve the effectiveness of the medication.

How It Works

Blood sugar is caused by imbalances in glucose regulation, which can result in problems with production, insulin action, or both. When the body does not produce insulin, glucose cannot efficiently enter the cells, leading to higher blood pressure.

Human Mixtard 30/70 Injection 40 IU 10ml helps to manage the blood sugar level in diabetic patients in both type 1 and type 2.

Safety Advice

Alcohol
Patients should avoid alcohol while taking Human Mixtard Injection because it interferes with the treatment and may cause dangerous fluctuations in blood pressure.
Pregnancy
Human Mixtard 30 Injection is not taken by pregnant women unless prescribed, as careful monitoring is required to manage blood pressure during pregnancy.
Breast Feeding
Women who breastfeed their child should avoid using Human Mixtard Injection as it may pass into breast milk and affect the baby.
Driving
Human Mixtard 30/70 Injection 40 IU 10ml may cause dizziness; it is possible to drive, but consult the doctor for proper advice before taking the medication
Kidney
Human Mixtard Injection is not used by kidney patients without medical supervision because the medicine can interrupt kidney function.
Liver
Consult a doctor before taking Human Mixtard 70 Injection if you are a patient of liver cancer, as liver function affects the effectiveness of the medication.

FAQs

Human Mixtard 70 Injection treats the blood sugar level in type 1 and type 2 diabetic patients.

It is most commonly used to provide insulin coverage, helping to control fasting throughout the day.

References

  • Lauritzen, T., Pramming, S., Gale, E. A., Deckert, T., & Binder, C. (1982). Absorption of isophane (NPH) insulin and its clinical implications. Br Med J (Clin Res Ed), 285(6336), 159-162. https://pubmed.ncbi.nlm.nih.gov/6807390/
  • Chandler, C., Gryniewicz, C. M., Pringle, T., & Cunningham, F. (2008). Insulin temperature and stability under simulated transit conditions. American Journal of Health-System Pharmacy, 65(10), 953-963. https://pubmed.ncbi.nlm.nih.gov/18463345/
  • Tunbridge, F. K., Newens, A., Home, P. D., Davis, S. N., Murphy, M., Burrin, J. M., ... & Jensen, I. (1989). Double-blind crossover trial of isophane (NPH)-and lente-based insulin regimens. Diabetes Care, 12(2), 115-119. https://pubmed.ncbi.nlm.nih.gov/2649324/
  • Owens, D. R., Jones, I. R., Birtwell, A. J., Burge, C. T. R., Luzio, S., Davies, C. J., ... & Heding, L. G. (1984). Study of porcine and human isophane (NPH) insulins in normal subjects. Diabetologia, 26(4), 261-265. https://pubmed.ncbi.nlm.nih.gov/6376233/
  • Henriksen, J. E., Vaag, A., Hansen, I. R., Lauritzen, M., Djurhuus, M. S., & Beck‐Nielsen, H. (1991). Absorption of NPH (isophane) insulin in resting diabetic patients: evidence for subcutaneous injection in the thigh as the preferred site. Diabetic medicine, 8(5), 453-457. https://pubmed.ncbi.nlm.nih.gov/1830531/

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Magicine PharmacopyCopyright 2026